Donanemab (Kisunla) for the Slowing of Alzheimer Disease.

Authors

Megan Adelman
Megan L Hull, OhioHealth

Document Type

Article

Publication Title

American family physician

First Page

320

Last Page

321

DOI

N/A

Publication Date

9-1-2025

Recommended Citation

Adelman M, Hull ML. Donanemab (Kisunla) for the Slowing of Alzheimer Disease. Am Fam Physician. 2025 Sep;112(3):320-321. PMID: 40961311.